VANCOUVER, BC, March 2, 2021 /CNW/ - Numinus Wellness Inc. (TSXV:NUMI)(OTCPK:LKYSF)("Numinus" or the "Company"), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychedelic-assisted psychotherapies (PAP), and Syreon Corporation (Syreon), a global contract … The company has a first-mover advantage because of its ketamine-enabled clinics and strong research team. 22.6k members in the shroomstocks community. By continuing to use our service, you agree to our use of cookies. The Company's Stock Option Plan allows for the issuance of up to 10% of issued and outstanding share capital in the form of incentive stock options. 1.7100-0.0300 (-1.72%) At close: 3:59PM EST. We also use them to share usage information … Until then, check back for more Starlink IPO news. Numinus Wellness Inc. It is also 20% higher than the previous record IPO year of 2000, which had 397. Stock analysis for Numinus Wellness Inc (NUMI:Venture) including stock price, stock chart, company news, key statistics, fundamentals and company profile. An icon used to represent a menu that can be toggled by interacting with this icon. Current stock quote for Numinus Wellness Inc. ( V.NUMI ) including financial statements, level 2 data, and the latest Drug Manufacturers - Major news, research, and investment community discussion Psychedelic stocks: HAVN gets off to a good start, Numinus shares in a funk, and COMPASS prepares to go public . Experten. by Charlie Smith on September 12th, 2020 at 7:02 AM. Annual stock financials by MarketWatch. Numinus Wellness Aktie: Aktueller Aktienkurs Charts Nachrichten Realtime WKN: A2P4XN | ISIN: CA67054W1032 12 Hot Upcoming IPOs to Watch For in 2021 The most exciting initial public offerings (IPOs) expected in 2021 range from a crypto exchange to an Amazon-backed EV play to a … And if you’re interested in IPO investing, check out our IPO Calendar to stay up-to-date on the market’s latest offerings. Posted by 9 days ago. Stocks in Play. 12. 17 votes, 11 comments. Payton Nyquvest and Stacey Wallin founded it in 2019, with its headquarters in Vancouver in … My average is 1.30 and I … Press J to jump to the feed. Numinus Wellness Inc. shares V.NUMI are trading down 7 cents at $1.73. This Numinus profile is part of a paid investor education campaign. Numinus Wellness (LKYSF - USD / NUMI.V CAD) Discussion. 8:23 4. 1 in 5 Canadians will suffer from addiction. Close. Press question mark to learn the rest of the keyboard shortcuts. Last Funding Type Post-IPO Equity; Legal Name Numinus Inc. Stock Symbol TSX:NUMI ; Company Type For Profit; Contact Email [email protected]numinus.ca; Phone Number tel:+1 604 336 2844; Numinus combines time-tested holistic methods with the power of neuro-technology to bring holistic healthcare to patients. 2,130 12. TSXV - TSXV Real Time Price. Log In Sign Up. This is +106% more than in 2019 with 233 IPOs. A community whose goal is to educate and prepare investors for the Mush Rush … Vancouver (www.aktiencheck.de, Anzeige) Einschätzung Strong OutperformerKurszieleKursziel 12M: 0,50 EUR … You can invest in companies before they start trading on a stock exchange. The Company’s operations include Numinus … This chart is not available. User account menu. Januar Analyse, Experten. Numinus Wellness (OTCPK:LKYSF): FQ1 Net loss of C$1.93M.Revenue of C$0.23M (+76.9% Y/Y)Press Release * Overview. Here’s how investors can buy pre-IPO stock and whether they should. Check out our LKYSF stock analysis, current LKYSF quote, charts, and historical prices for Numinus Wellness Inc stock When will Starlink IPO? Tweet. Cookies are used to offer you a better browsing experience and to analyze our traffic. Stockhouse.com use cookies on this site. 1 in 11 Canadians will have PTSD in their lifetime. Numinus (TSXV: NUMI) OTC: LKYSF | USD $1.23 | +0.04% Numinus Wellness is a publicly-traded company that is licensed (via Salvation Botanicals) by Health Canada to test, sell and distribute psychedelic substances. Current stock quote for Numinus Wellness Inc. ( V.NUMI ) including financial statements, level 2 data, and the latest Drug Manufacturers - Major news, research, and investment community discussion I was watching this stock closely from the fall of 2020 when they were around .40 cents and have been on a consistent grow.